PRESS RELEASE published on 07/29/2025 at 20:16, 9 months 11 days ago Inside Information / Other news releases Poxel provides update on negotiations with creditors, announces reorganization proceedings & corporate governance change with trading suspension. Press release details Lyon Court filing for insolvency & governance impact Governance Creditors Reorganization Trading Suspension Poxel
PRESS RELEASE published on 07/29/2025 at 20:16, 9 months 11 days ago Informations privilégiées / Autres communiqués Poxel annonce dépôt requête redressement judiciaire, changement gouvernance, suspension cotation. Négociations créanciers et transition opérationnelle en cours Gouvernance Créanciers Transition Redressement Judiciaire Poxel
BRIEF published on 07/08/2025 at 18:51, 10 months 1 day ago Informations sur le capital et les droits de vote de Poxel Droits De Vote Capital Social Actions AMF Poxel
BRIEF published on 07/08/2025 at 18:51, 10 months 1 day ago Information on Poxel's capital and voting rights Share Capital Voting Rights Actions AMF Poxel
PRESS RELEASE published on 07/08/2025 at 18:46, 10 months 1 day ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Poxel communique le nombre total d'actions et de droits de vote composant son capital social conformément à la réglementation AMF Capital Social Actions AMF Réglementé Poxel
BRIEF published on 06/19/2025 at 17:51, 10 months 20 days ago Key Scientific Presentations on Imeglimin at ADA 2025 Diabetes Therapeutic Potential Sumitomo Pharma Imeglimin Scientific Presentations
BRIEF published on 06/19/2025 at 17:51, 10 months 20 days ago Présentations scientifiques clés sur l'Imeglimine à l'ADA 2025 Diabète Présentations Scientifiques Sumitomo Pharma Potentiel Thérapeutique Iméglimine
PRESS RELEASE published on 06/19/2025 at 17:46, 10 months 20 days ago Inside Information / Other news releases Poxel presents new Imeglimin data at ADA 2025 diabetes conference, highlighting therapeutic potential. Key presentations by Japanese experts Diabetes Therapeutic Potential Poxel Imeglimin ADA 2025
PRESS RELEASE published on 06/19/2025 at 17:46, 10 months 20 days ago Informations privilégiées / Autres communiqués Des leaders d'opinion présentent le potentiel thérapeutique de l'Imeglimine lors de l'ADA 2025, le plus grand congrès sur le diabète. POXEL SA annonce cinq présentations à Chicago, Illinois Congrès Diabète Poxel SA Iméglimine ADA 2025
BRIEF published on 06/06/2025 at 19:10, 11 months 3 days ago Poxel : Détails sur le capital social et les droits de vote Droits De Vote Capital Social Actions Informations Réglementées Poxel
Published on 05/09/2026 at 01:30, 1 day 15 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 17 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 1 hour 9 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 3 hours 14 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 5 hours 29 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 22 hours 9 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 20 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 2 days 21 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 21 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 22 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 22 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 22 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
